1 study on Insulin receptors mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This extensive review underscores the significant therapeutic potential of PTP1B inhibitors as a novel class of drugs for Type 2 Diabetes, offering a direct approach to reverse insulin resistance. By targeting PTP1B (…